BABIO Launches Filariasis IgG/IgM Rapid Test Kit to Support Global Filarial Disease Diagnosis

- 2025-04-30-

BABIO Launches Filariasis IgG/IgM Rapid Test Kit to Support Global Filarial Disease Diagnosis


BABIO, a leading Chinese manufacturer of diagnostic medical devices, has introduced the Filariasis IgG/IgM Test Kit (Colloidal Gold)—a fast, accurate, and easy-to-use lateral flow immunoassay for the detection of lymphatic filarial parasites (Wuchereria bancrofti and Brugia malayi). The kit enables simultaneous detection of IgG and IgM antibodies in serum, plasma, or whole blood, making it a powerful tool in screening and early diagnosis of filariasis across Africa, Southeast Asia, and emerging global markets.

Lymphatic filariasis is a neglected tropical disease (NTD) affecting over 120 million people globally. Early detection remains critical for successful treatment and prevention of long-term complications such as lymphedema and elephantiasis.

Key Features of BABIO's Filariasis IgG/IgM Test Kit

  • ✅ Simultaneous IgG and IgM Detection
    Distinguishes between recent (IgM) and past (IgG) infections for better clinical decision-making.

  • ✅ Rapid Results in 15 Minutes
    Visual results appear as early as 1 minute and are clearly readable within 10–15 minutes.

  • ✅ User-Friendly Design
    No special equipment required. Ideal for field settings, rural clinics, and low-resource environments.

  • ✅ High Sensitivity and Specificity
    Optimized for early-stage detection of W. bancrofti and B. malayi infections.

  • ✅ Multipurpose Sample Compatibility
    Works with whole blood, serum, or plasma, offering broad diagnostic flexibility.

Applications and Global Impact

The kit is highly suitable for:

  • Mass screening programs in endemic regions

  • Use by NGOs, public health agencies, and hospitals

  • Outbreak response and epidemiological surveys

  • Travel medicine and clinical laboratories

By enabling rapid diagnosis, the BABIO Filariasis Test Kit plays a crucial role in breaking the transmission cycle and achieving global health goals for neglected tropical diseases (NTDs).

Test Procedure Overview

  1. Bring all components to room temperature before use.

  2. Apply sample (whole blood, serum, or plasma) to the test well.

  3. Add 2 drops of sample diluent.

  4. Read results between 10–15 minutes (do not interpret after 15 minutes).

  5. Interpretation:

    • C line only: Negative

    • C + M line: IgM Positive

    • C + G line: IgG Positive

    • C + M + G lines: Dual Positive

    • No C line: Invalid – retest required

Global Availability & Quality Assurance

Produced under strict manufacturing standards in China, BABIO’s test kits are exported worldwide and comply with international safety, sensitivity, and stability guidelines. The test kits are shelf-stable for up to 12 months and can be transported across varied temperature conditions (2–37°C).

About BABIO

With a global reputation for innovation, reliability, and affordability, BABIO is a top Chinese biotech manufacturer of rapid diagnostic test kits for infectious diseases, tropical medicine, and clinical diagnostics. We serve healthcare providers, public health agencies, and laboratories across Europe, Africa, the Americas, and Asia.

Free samples and bulk orders are available upon request.
 Visit our official website to learn more：https://www.babiocorp.com